Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer
皮下注射曲妥珠单抗居家给药的安全性和耐受性:HER2阳性早期乳腺癌IIIb期开放标签BELIS研究结果
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-020-05604-7
Denys, Hannelore; Martinez-Mena, Corina L; Martens, Marc T; D'Hondt, Randal G; Graas, Marie-Pascale L; Evron, Ella; Fried, Georgeta; Ben-Baruch, Noa E; Vulsteke, Christof; Van Steenberghe, Mona M